News
“Staying Forever Young”: H2 Global Group Brings a Hydrogen Standard to the Longevity Sector
Prague, 3 December 2025 (PROTEXT) – The longevity market is experiencing a global boom. More and more people are...
H2 Global Group – Press Conference at ČTK
Molecular Hydrogen and Dementia Prevention: Czech Research Heads into Its First Clinical Study Today, on 12 November...
H2 Global Group – Our Story
It has been nearly 14 years since David Maršálek happened to meet Professor Dušan Miljković in the USA – the man who...
“Alzheimer’s dementia: a breakthrough gentle Czech solution turns a problem into an opportunity. And investors don’t want to miss out.”
Precisely in this field comes news from the Czech Republic with the potential to place the country on the map of world...
Czech Breakthrough in Medicine: H2 Global Group Receives Regulatory Approval for Hydrogen Clinical Study — New Era in Alzheimer’s Therapy Begins
European innovation leader H₂ Global Group today announced that its subsidiary H₂ Medical Technologies has received...
H2 Longevity®: The Czech Hydrogen-Based Longevity Revolution Conquering the World
The Czech company H2 Global Group, a world leader in the HealthTech and MedTech sectors with more than 13 years of research and development in the field of Molecular Hydrogen®, presents its latest exclusive project – the H2 Longevity® longevity center.